RLMD
#3058
Relmada Therapeutics, Inc. - Common Stock
3.5 1 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.54%
Monthly Change
-22.52%
6 month change
-53.07%
Year Change
+77.27%
Previous Close
3.3 9
Open
3.3 9
Low
3.3 2
High
3.5 3
Financials
2017
Quarterly report, Q2 FY2018
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2018
10-Q
Quarterly report, Q1 FY2018
RELMADA THERAPEUTICS, INC. quarterly report, Q1 FY2018
10-Q
Current report, 28 Sep 2017
RELMADA THERAPEUTICS, INC. current report, 28 September 2017
8-K
Annual report, FY2017
RELMADA THERAPEUTICS, INC. annual report, FY2017
10-K
Current report, 12 Jun 2017
RELMADA THERAPEUTICS, INC. current report, 12 June 2017
8-K
Current report, 06 Jun 2017
RELMADA THERAPEUTICS, INC. current report, 06 June 2017
8-K
Current report, 16 May 2017
RELMADA THERAPEUTICS, INC. current report, 16 May 2017
8-K
Current report, 21 Apr 2017
RELMADA THERAPEUTICS, INC. current report, 21 April 2017
8-K
Quarterly report, Q3 FY2017
RELMADA THERAPEUTICS, INC. quarterly report, Q3 FY2017
10-Q
Current report, 13 Feb 2017
RELMADA THERAPEUTICS, INC. current report, 13 February 2017
8-K